Studies on the in vitro assembly of Aβ 1-40:: Implications for the search for Aβ fibril formation inhibitors

被引:255
作者
Goldsbury, CS [1 ]
Wirtz, S
Müller, SA
Sunderji, S
Wicki, P
Aebi, U
Frey, P
机构
[1] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, CH-4002 Basel, Switzerland
关键词
A beta; fibril formation; Alzheimer's disease; thioflavin T; fluorescence; Congo red; turbidity; electron microscopy;
D O I
10.1006/jsbi.2000.4259
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The progressive deposition of the amyloid beta peptide (A beta) in fibrillar form is a key feature in the development of the pathology in Alzheimer's disease (AD). We have characterized the time course of A beta fibril formation using a variety of assays and under different experimental conditions. We describe in detail the morphological development of the A beta polymerization process from pseudo-spherical structures and protofibrils to mature thioflavin-T-positive/Congo red-positive amyloid fibrils. Moreover, we structurally characterize the various polymorphic fibrillar assemblies using transmission electron microscopy and determine their mass using scanning transmission electron microscopy. These results provide the framework for future investigations into how target compounds may interfere with the polymerization process. Such substances might have a therapeutic potential in AD. (C) 2000 Academic Press.
引用
收藏
页码:217 / 231
页数:15
相关论文
共 64 条
  • [1] ARCHITECTURE AND POLYMORPHISM OF FIBRILLAR SUPRAMOLECULAR ASSEMBLIES PRODUCED BY IN-VITRO AGGREGATION OF HUMAN CALCITONIN
    BAUER, HH
    AEBI, U
    HANER, M
    HERMANN, R
    MULLER, M
    ARVINTE, T
    MERKLE, HP
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 1995, 115 (01) : 1 - 15
  • [2] Morphological development of β(1-40) amyloid fibrils
    Blackley, HKL
    Patel, N
    Davies, MC
    Roberts, CJ
    Tendler, SJB
    Wilkinson, MJ
    Williams, PM
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 158 (02) : 437 - 443
  • [3] Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide
    Bradt, BM
    Kolb, WP
    Cooper, NR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) : 431 - 438
  • [4] Molecular modeling of the Aβ1-42 peptide from Alzheimer's disease
    Chaney, MO
    Webster, SD
    Kuo, YM
    Roher, AE
    [J]. PROTEIN ENGINEERING, 1998, 11 (09): : 761 - 767
  • [5] X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS
    EANES, ED
    GLENNER, GG
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1968, 16 (11) : 673 - &
  • [6] Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease
    El Khoury, J
    Hickman, SE
    Thomas, CA
    Loike, JD
    Silverstein, SC
    [J]. NEUROBIOLOGY OF AGING, 1998, 19 (01) : S81 - S84
  • [7] POLYMORPHISM OF RECONSTITUTED HUMAN EPIDERMAL KERATIN FILAMENTS - DETERMINATION OF THEIR MASS-PER-LENGTH AND WIDTH BY SCANNING-TRANSMISSION ELECTRON-MICROSCOPY (STEM)
    ENGEL, A
    EICHNER, R
    AEBI, U
    [J]. JOURNAL OF ULTRASTRUCTURE RESEARCH, 1985, 90 (03): : 323 - 335
  • [8] Engel Andreas, 1993, Current Opinion in Biotechnology, V4, P403, DOI 10.1016/0958-1669(93)90005-H
  • [9] A beta deposition inhibitor screen using synthetic amyloid
    Esler, WP
    Stimson, ER
    Ghilardi, JR
    Felix, AM
    Lu, YA
    Vinters, HV
    Mantyh, PW
    Maggio, JE
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (03) : 258 - 263
  • [10] Modified-peptide inhibitors of amyloid β-peptide polymerization
    Findeis, MA
    Musso, GM
    Arico-Muendel, CC
    Benjamin, HW
    Hundal, AM
    Lee, JJ
    Chin, J
    Kelley, M
    Wakefield, J
    Hayward, NJ
    Molineaux, SM
    [J]. BIOCHEMISTRY, 1999, 38 (21) : 6791 - 6800